OncoDNA expands reach to North America

By LabPulse.com staff writers

January 8, 2021 -- OncoDNA has signed a subcontract service agreement with HalioDx's U.S.-based CLIA-certified laboratory in Richmond, VA. The agreement expands the France-based firm's reach to biopharmaceutical companies and research institutions in North America.

OncoDNA's products and services are already available in 50 countries. The firm's personalized cancer therapies are currently used in pan-European clinical trials and research projects, such as Kura Oncology's HRAS tipifarnib clinical study and the Aurora metastatic breast cancer research program.


Copyright © 2021 LabPulse.com
 

To read this and get access to all of the exclusive content on LabPulse.com, create a free account or sign in now.

Member Sign In:
MemberID or email address:  
Do you have a LabPulse.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Forgot your password?
|
View our privacy policy.